Clinical trials have demonstrated the safety of TMS therapy in over 10,000 active treatments.
Treatment with TMS caused very few side effects and was generally well tolerated by patients. The most common side effect reported during clinical trials was scalp discomfort, generally mild to moderate and occurring less frequently after the first week of treatment.
Fewer than 5% of patients discontinued treatment with NeuroStar TMS Therapy due to adverse events.
- No systemic side effects
- No weight gain
- No sexual dysfunction
- No sedation
- No nausea
- No dry mouth
- No adverse effects on concentration or memory
- No drug interactions
TMS is not recommended for patients in the following categories:
- Patients with implanted metallic devices or non-removable metallic objects in or around the head. This does not include metallic fillings in teeth!
- Patients with implants controlled by physiological signals. This includes pacemakers, implantable cardioverter defibrillators (ICDs), and vagus nerve stimulators (VNS).